• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    JanOne Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    7/17/24 2:55:12 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate
    Get the next $JAN alert in real time by email
    false --12-31 0000862861 0000862861 2024-07-15 2024-07-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): July 15, 2024

     

     

     

    ALT5 Sigma Corporation

    (Exact Name of Registrant as Specified in Charter)

     

     

     

    Nevada 000-19621 41-1454591
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)

     

    325 E. Warm Springs Road, Suite 102

    Las Vegas, NV 89119

    (Address of Principal Executive Offices and Zip Code)

     

    Registrant’s telephone number, including area code: 702-997-5968

     

    JanOne Inc.

    (Former Name or Former Address, if Changed Since Last Report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.001 par value per share   ALTS  

    The NASDAQ Stock Market LLC

    (The NASDAQ Capital Market)

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Section 5 – Corporate Governance and Management

     

    Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

     

    Effective July 15, 2024, JanOne Inc. (the “Company”) changed its corporate name from JanOne Inc. to ALT5 Sigma Corporation, and also changed its Nasdaq common stock ticker symbol from “JAN” to “ALTS”. The name change was effected through a parent/subsidiary short-form merger of ALT5 Sigma Corporation, our wholly-owned Nevada subsidiary formed solely for the purpose of effectuating the name change (the “Name Change Subsidiary”), whereby it merged with and into the Company, with the Company being the surviving entity. In preparation for the name-change merger, we filed Articles of Incorporation of the Name Change Subsidiary with the Secretary of State of the State of Nevada on July 10, 2024. A copy of those Articles of Incorporation is attached hereto as Exhibit 3.19. Then, on July 11, 2024, to effectuate the name change, we filed Articles of Merger between the Name Change Subsidiary and us with the Secretary of State of the State of Nevada. A copy of the Articles of Merger is attached hereto as Exhibit 3.20. The name-change merger became effective on July 15, 2024. Our Board of Directors approved the name-change merger and, in accordance with Section 92A.180 of the Nevada Revised Statutes, approval by our stockholders was not required. Further, our website address changed from “janone.com” to “alt5sigma.com.” No action by our stockholders was required with respect to the ticker symbol change. Our CUSIP number and transfer agent remain unchanged.

     

    Section 7 – Regulation FD

     

    7.01. Regulation FD Disclosure.

     

    On July 12, 2024, we issued a press release announcing our then-upcoming name and ticker symbol change. A copy of the press release is furnished as Exhibit 99.1 hereto.

     

    The information in this Item 7.01, including Exhibits 99.1 and 99.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any of our filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by reference in such filing.

     

    Section 9 – Financial Statements and Exhibits

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit No.   Description
    3.19   Articles of Incorporation of ALT5 Sigma Corporation (the Name Change Subsidiary), filed with the Secretary of State for the State of Nevada on July 10, 2024.
    3.20   Articles of Merger for ALT5 Sigma Corporation with and into JanOne Inc., filed with the Secretary of State for the State of Nevada on July 11, 2024, and effective on July 15, 2024.
    99.1   Press Release, dated July 12, 2024.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    2
     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, we have duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      ALT5 Sigma Corporation
         
      By: /s/ Tony Isaac
      Name: Tony Isaac
      Title: Chief Executive Officer
         
    Dated: July 17, 2024    

     

    3

    Get the next $JAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $JAN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $JAN
    SEC Filings

    View All

    Janus Living Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Janus Living, Inc. (0002100805) (Filer)

    3/23/26 4:05:45 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 424B4 filed by Janus Living Inc.

    424B4 - Janus Living, Inc. (0002100805) (Filer)

    3/23/26 6:02:41 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    SEC Form S-8 filed by JanOne Inc.

    S-8 - Janus Living, Inc. (0002100805) (Filer)

    3/20/26 8:18:24 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    $JAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $JAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Janus Living Closes on a New $600 Million Credit Facility to Enhance Liquidity and Support External Growth

    Janus Living, Inc. (NYSE:JAN) ("Janus Living"), a pure-play senior housing real estate investment trust (REIT), announced today that it has closed on a new $500 million unsecured revolving credit facility (the "Revolving Facility") and a $100 million unsecured delayed-draw term loan facility (the "Term Loan", and together with the Revolving Facility, the "Credit Facility"). The Revolving Facility provides for borrowing up to $500 million and matures in March 2030, with two six-month extension options. The $100 million Term Loan includes a delayed-draw feature and matures in March 2031. Borrowings under the Revolving Facility and Term Loan bear interest at SOFR plus 105 and 110 basis poi

    3/23/26 4:16:00 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering

    Healthpeak Properties, Inc. (NYSE:DOC) ("Healthpeak") and Janus Living, Inc. (NYSE:JAN) ("Janus Living") announced today that Janus Living has completed its initial public offering of 48,300,000 shares of its Class A-1 common stock, which includes the exercise in full by the underwriters of their option to purchase up to an additional 6,300,000 shares of Class A-1 common stock, at a price to the public of $20.00 per share. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323402409/en/ Shares of Janus Living's Class A-1 common stock began trading on the New York Stock Exchange on March 20, 2026 under the ticker symbol "JAN." T

    3/23/26 4:15:00 PM ET
    $DOC
    $JAN
    Real Estate Investment Trusts
    Real Estate

    NYSE Content Update: Senior Housing REIT Janus Living to Make Public Debut

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 20, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on March 20thMarkets are lower Friday morning after Israeli Prime Minister Benjamin Netanyahu said his country was assisting the U.S. in reopening the Strait of Hormuz.Janus Living (NYSE:JAN) will begin trading on the NYSE today and celebrates its IPO on-site this morning.Guardian Metal Resources CEO & Executive Director Olive

    3/20/26 8:55:00 AM ET
    $ICE
    $JAN
    Investment Bankers/Brokers/Service
    Finance
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Sandstrom Katherine M

    4 - Janus Living, Inc. (0002100805) (Issuer)

    3/24/26 5:18:34 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Porter Tracy A

    4 - Janus Living, Inc. (0002100805) (Issuer)

    3/24/26 5:17:59 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Patadia Ankit B.

    4 - Janus Living, Inc. (0002100805) (Issuer)

    3/24/26 5:17:18 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    $JAN
    Financials

    Live finance-specific insights

    View All

    JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment

    -The board has approved a strategic review of the biotech assets and ALT5 Sigma being the core focus going forward- -The company is intending a name and stock symbol change to reflect this decision- LAS VEGAS, July 10, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on fintech and healthcare, has announced plans to enhance stockholder value through a visionary strategic realignment, entailing a redeployment of biotech assets and a change of its name. The plan, unanimously approved by the company's board and following the May acquisi

    7/10/24 8:30:00 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    JanOne Inc. Completes Acquisition of Soin Therapeutics, LLC

    The acquisition of Soin provides JanOne with its second, late stage clinical stage asset LAS VEGAS, Jan. 10, 2023 /PRNewswire/ -- JanOne Inc. ("JanOne") (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that it has completed the acquisition of Soin Therapeutics, LLC and its product, a patent-pending, novel formulation of low-dose naltrexone. This all stock transaction has a value of $13M, with up to an additional $17M depending on revenues generated by the product, for a total value of up to $30M. The transaction includes restrictions on the maximum number of shares of preferred stock and common stock that can be i

    1/10/23 8:30:00 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use Disorder

    LAS VEGAS, Dec. 7, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties - in an effort to further reduce the drug addiction epidemic - today announced an option agreement for the rights to a novel strategy to reduce methamphetamine (meth) use by activating the Translocator Protein 18 kDa (TSPO).  The agreement with LSU Health Shreveport, along with other intellectual property relating to TSPO's role in treating meth use disorder (MUD), provides JanOne Inc. with an opportunity to identify new drugs to enhance TSPO activity, and by doing so, reducing craving for meth. This new strategy for treating MUD w

    12/7/21 9:00:00 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    $JAN
    Leadership Updates

    Live Leadership Updates

    View All

    ALT5 Sigma Welcomes FinTech Executive, Ron Pitters to Its Board of Directors

    LAS VEGAS, NV / ACCESSWIRE / November 6, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS) ("ALT5" or the "Company"), a fintech innovator providing next-generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and secure storage of digital assets, is pleased to announce the appointment of Mr. Ron Pitters to its Board of Directors."We are thrilled to welcome industry veteran, Ron Pitters, to our Board. With a unique blend of experience in both traditional finance and disruptive blockchain technologies, Ron brings invaluable insights. His proven track record, spanning from startups to multinational corporations, makes him a fantastic addition to our team,"

    11/6/24 8:30:00 AM ET
    $ALTS
    $JAN
    Finance: Consumer Services
    Finance
    Real Estate Investment Trusts
    Real Estate

    JanOne Appoints Vay Tham as its Chief Revenue Officer and President of its Fintech Subsidiary, ALT5 Sigma

    LAS VEGAS, June 26, 2024 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a multidisciplinary organization with a focus on healthcare and fintech, is pleased to announce that it has appointed Mr. Vay Tham as its Chief Revenue Officer and President of ALT5 Sigma, Inc., its wholly-owned subsidiary. Mr. Tham brings extensive experience in capital markets, particularly in technology sectors, spanning over 25 years. His career includes roles in research, investment banking, and finance, notably and most recently as Managing Director and Head of Technology Investment Banking at PI Financial Corp. (Ventum Financial).

    6/26/24 7:30:00 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board

    LAS VEGAS, June 15, 2021 /PRNewswire/ -- JanOne Inc. (NASDAQ:JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world's leaders on the role of stress in drug addiction.  Tony Isaac, President and Chief Executive Officer of JanOne, commented, "JanOne's mission is to develop non-addictive medications to treat diseases that cause severe pain, thereby m

    6/15/21 10:15:00 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    $JAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

    SC 13G/A - JanOne Inc. (0000862861) (Subject)

    8/24/23 4:30:55 PM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by JanOne Inc.

    SC 13G - JanOne Inc. (0000862861) (Subject)

    3/27/23 9:00:21 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G/A filed by JanOne Inc. (Amendment)

    SC 13G/A - JanOne Inc. (0000862861) (Subject)

    2/11/22 6:07:45 AM ET
    $JAN
    Real Estate Investment Trusts
    Real Estate